Alexander Maxwell Menzies

机构：The University of Sydney, Mater Health Services, Royal North Shore Hospital, Melanoma Institute Australia, Mater Private Hospital · ORCID：0000-0001-5183-7562

发表论文 758 篇 · 总被引 33208 次 · h-index 86

代表论文

• Pancreatic volume and immune biomarkers predict checkpoint inhibitor–associated autoimmune diabetes in humans (2025 · Journal of Clinical Investigation · 被引 3)
• Real‐World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations (2025 · Cancer Medicine · 被引 1)
• Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases (2026 · Journal for ImmunoTherapy of Cancer)
• Immunotherapy for early-stage cutaneous squamous cell carcinoma (2026 · Journal for ImmunoTherapy of Cancer)
• Vulval Lichen Sclerosus Associated With Immune Checkpoint Inhibitor Therapy: A Case Series of 11 Patients (2026 · Australasian Journal of Dermatology)
• Clinical outcomes and management following progressive disease with anti-PD-(L)1 therapy in patients with advanced cutaneous squamous cell carcinoma (2026 · EJC Skin Cancer)